JPS56138112A - Suppository containing ascorbic acid or sodium ascorbate - Google Patents
Suppository containing ascorbic acid or sodium ascorbateInfo
- Publication number
- JPS56138112A JPS56138112A JP4036880A JP4036880A JPS56138112A JP S56138112 A JPS56138112 A JP S56138112A JP 4036880 A JP4036880 A JP 4036880A JP 4036880 A JP4036880 A JP 4036880A JP S56138112 A JPS56138112 A JP S56138112A
- Authority
- JP
- Japan
- Prior art keywords
- ascorbic acid
- sodium ascorbate
- suppository
- containing ascorbic
- suppository containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 8
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 4
- 239000011668 ascorbic acid Substances 0.000 title abstract 4
- 229960005070 ascorbic acid Drugs 0.000 title abstract 4
- 239000000829 suppository Substances 0.000 title abstract 4
- 235000010378 sodium ascorbate Nutrition 0.000 title abstract 3
- 229960005055 sodium ascorbate Drugs 0.000 title abstract 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 title abstract 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000055006 Calcitonin Human genes 0.000 abstract 1
- 108060001064 Calcitonin Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
- 229960004015 calcitonin Drugs 0.000 abstract 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- -1 heparin Chemical compound 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000813 peptide hormone Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4036880A JPS56138112A (en) | 1980-03-31 | 1980-03-31 | Suppository containing ascorbic acid or sodium ascorbate |
| EP81102336A EP0037943B1 (en) | 1980-03-31 | 1981-03-27 | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
| DE8181102336T DE3171774D1 (en) | 1980-03-31 | 1981-03-27 | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
| US06/249,462 US4434159A (en) | 1980-03-31 | 1981-03-31 | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4036880A JPS56138112A (en) | 1980-03-31 | 1980-03-31 | Suppository containing ascorbic acid or sodium ascorbate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56138112A true JPS56138112A (en) | 1981-10-28 |
| JPS631923B2 JPS631923B2 (enrdf_load_stackoverflow) | 1988-01-14 |
Family
ID=12578692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4036880A Granted JPS56138112A (en) | 1980-03-31 | 1980-03-31 | Suppository containing ascorbic acid or sodium ascorbate |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS56138112A (enrdf_load_stackoverflow) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01279839A (ja) * | 1988-04-30 | 1989-11-10 | Nitto Denko Corp | 水溶性生理活性蛋白質製剤 |
| WO1991017742A1 (fr) * | 1988-12-07 | 1991-11-28 | Ss Pharmaceutical Co., Ltd. | Supositoire a liberation entretenue |
| JP2015120766A (ja) * | 2009-01-09 | 2015-07-02 | ロート製薬株式会社 | ジフェンヒドラミン又はその塩並びにアスコルビン酸又はその塩を含有する外用組成物の変色抑制方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3210663B2 (ja) * | 1990-04-06 | 2001-09-17 | エーザイ株式会社 | カテコール化合物を含有する経口用固形製剤 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55153712A (en) * | 1979-05-18 | 1980-11-29 | Kao Corp | Insulin pharmaceutical preparation and its production |
-
1980
- 1980-03-31 JP JP4036880A patent/JPS56138112A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55153712A (en) * | 1979-05-18 | 1980-11-29 | Kao Corp | Insulin pharmaceutical preparation and its production |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01279839A (ja) * | 1988-04-30 | 1989-11-10 | Nitto Denko Corp | 水溶性生理活性蛋白質製剤 |
| WO1991017742A1 (fr) * | 1988-12-07 | 1991-11-28 | Ss Pharmaceutical Co., Ltd. | Supositoire a liberation entretenue |
| US5500221A (en) * | 1988-12-07 | 1996-03-19 | Ss Pharmaceutical Co., Ltd. | Sustained release suppository |
| JP2015120766A (ja) * | 2009-01-09 | 2015-07-02 | ロート製薬株式会社 | ジフェンヒドラミン又はその塩並びにアスコルビン酸又はその塩を含有する外用組成物の変色抑制方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS631923B2 (enrdf_load_stackoverflow) | 1988-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK28984A (en) | Composition and method for combating virus infections | |
| IL76119A0 (en) | Initiating reperfusion treatment when heart attack symptoms are present | |
| ES2117642T3 (es) | Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles. | |
| JPS56100714A (en) | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane | |
| ES8201596A1 (es) | Procedimiento de obtencion de mucopolisacaridos | |
| JPS53113008A (en) | Constant rate releasing preparation | |
| JPS56104815A (en) | Remedy for peripheral orthostatic hypotension | |
| GR78416B (enrdf_load_stackoverflow) | ||
| JPS56138111A (en) | Suppository containing unsaturated fatty acid or salt thereof | |
| PT78628B (en) | Pharmaceutical composition with reduced toxicity | |
| JPS5551020A (en) | Remedy for rheumatism | |
| JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
| JPS56138112A (en) | Suppository containing ascorbic acid or sodium ascorbate | |
| KR920702225A (ko) | 약학 조성물 | |
| JPS56138115A (en) | Suppository containing acidic amino acid or derivative thereof | |
| JPS52105220A (en) | Composition for rectal administration comprising beta-lactam ring containing substance and method of making same | |
| JPS56122310A (en) | Suppository | |
| JPS5470428A (en) | Carcinostatic agent | |
| JPS53148518A (en) | Stabilized prostaglandin e composition and its preparation | |
| JPS57144214A (en) | Pharmaceutical preparation for rectum medication | |
| JPS5639019A (en) | Antiviral agent | |
| JPS5569510A (en) | Carcinostatic agent | |
| KR900701311A (ko) | 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법 | |
| JPS646214A (en) | Remedy for ulcerative colonopathy | |
| KR830008678A (ko) | 진통 조성물 |